Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.000
+0.130 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Employees
Kyverna Therapeutics had 96 employees as of December 31, 2023.
Employees
96
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,152,656
Market Cap
172.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 96 | - | - |
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Coherus BioSciences | 306 |
Alector | 244 |
Lyell Immunopharma | 224 |
Genfit | 159 |
BrainsWay | 134 |
EUDA Health Holdings | 106 |
MediWound | 100 |
KYTX News
- 1 hour ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc - Accesswire
- 1 day ago - Kyverna Therapeutics Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law Firm - Accesswire
- 1 day ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - GlobeNewsWire
- 2 days ago - Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX - PRNewsWire
- 2 days ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc. - Accesswire
- 3 days ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PRNewsWire
- 3 days ago - Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Assist The Schall Law Firm - Accesswire
- 4 days ago - The Schall Law Firm Urges Stockholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc - Accesswire